Patients who need older, unprofitable medications can be overlooked by the pharmaceutical industry and federal drug regulator ...

Synthetic biologists were tantalized by the idea of making mirror images of microbes. Then things got complicated.

Nina Notman meets the scientists developing recombinant antivenoms and small molecule inhibitors to save the lives and limbs of snakebite patients, who number in the their hundreds of thousands ...

US startup Bond Pet Foods has welcomed Germany's Symrise as an investor, with the firms partnering to create new ...

Product from Wockhardt, the last remaining maker of porcine insulin, likely won’t be available for regular sale as patients ...

When he was a doctoral student at the University of Copenhagen, Eske Willerslev was a nobody. At least, that’s how it seemed to the budding evolutionary geneticist, who was unable to lay his hands on ...

A massive study of ancient DNA from nearly 16,000 people across more than 10,000 years in West Eurasia reveals that natural ...

This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...

This paper provides a valuable observation that imiquimod, a compound often used to induce a psoriasis-like skin inflammation in mice, has a TLR7-independent effect acting through the unfolded protein ...

SYNGULON SRL, a biotechnology company specializing in genetic technologies for industrial fermentation, and Elanco Animal Health Incorporated, a global leader in animal health, today announced Elanco ...

Sign up for the Slatest to get the most insightful analysis, criticism, and advice out there, delivered to your inbox daily. A redacted correspondent, who sounds to ...